{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:54:42Z","timestamp":1760784882065},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"1.3.5 project for disciplines of excellence","award":["ZYGD18012"],"award-info":[{"award-number":["ZYGD18012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1245\/s10434-020-09003-6","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:03:57Z","timestamp":1597345437000},"page":"975-984","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels"],"prefix":"10.1245","volume":"28","author":[{"given":"Libo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjie","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"1","key":"9003_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13058-017-0819-4","volume":"19","author":"LE Elshof","year":"2017","unstructured":"Elshof LE, Schaapveld M, Rutgers EJ, et al. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study. Breast Cancer Res. 2017;19(1):26.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"9003_CR2","first-page":"277","volume":"165","author":"IA Olivotto","year":"2001","unstructured":"Olivotto IA, Bancej C, Goel V, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001;165(3):277\u201383.","journal-title":"CMAJ"},{"issue":"9","key":"9003_CR3","first-page":"25","volume":"20","author":"Armed Forces Health Surveillance Center","year":"2013","unstructured":"Armed Forces Health Surveillance Center. Incident diagnoses of breast cancer, active component service women, U.S. Armed Forces, 2000\u20132012. MSMR. 2013;20(9):25\u20137.","journal-title":"MSMR"},{"issue":"6","key":"9003_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jamcollsurg.2019.01.018","volume":"228","author":"TO Oseni","year":"2019","unstructured":"Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC. Twenty-five year trends in the incidence of ductal carcinoma in situ in US Women. J Am Coll Surg. 2019;228(6):932\u20139.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"9003_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285\u201392.","journal-title":"Br J Cancer"},{"issue":"5","key":"9003_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","volume":"267","author":"LE Elshof","year":"2018","unstructured":"Elshof LE, Schmidt MK, Rutgers EJT, van Leeuwen FE, Wesseling J, Schaapveld M. Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann Surg. 2018;267(5):952\u20138.","journal-title":"Ann Surg"},{"issue":"2","key":"9003_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-015-3472-6","volume":"152","author":"VC Koh","year":"2015","unstructured":"Koh VC, Lim JC, Thike AA, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152(2):293\u2013304.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"9003_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1(7):888\u201396.","journal-title":"JAMA Oncol"},{"issue":"22","key":"9003_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/jnci\/djg097","volume":"95","author":"K Kerlikowske","year":"2003","unstructured":"Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692\u2013702.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"9003_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser MD, Weaver DL, Zhao F, et al. Cancer outcomes in DCIS patients without locoregional treatment. J Natl Cancer Inst. 2019;111(9):952\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"9003_CR11","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30\u00a0years of long-term follow-up. Cancer. 2005;103(12):2481\u20134.","journal-title":"Cancer"},{"issue":"1","key":"9003_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11864-012-0217-1","volume":"14","author":"N Bijker","year":"2013","unstructured":"Bijker N, Donker M, Wesseling J, den Heeten GJ, Rutgers EJ. Is DCIS breast cancer, and how do I treat it? Curr Treat Options Oncol. 2013;14(1):75\u201387.","journal-title":"Current treatment options in oncology"},{"issue":"8","key":"9003_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano G, Burstein HJ, Winer EP, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol. 2017;28(8):1700\u201312.","journal-title":"Ann Oncol"},{"issue":"21","key":"9003_CR14","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853: a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381\u20137.","journal-title":"J Clin Oncol"},{"issue":"5","key":"9003_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/02841860600681569","volume":"45","author":"SO Emdin","year":"2006","unstructured":"Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006;45(5):536\u201343.","journal-title":"Acta Oncol"},{"issue":"9203","key":"9003_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(99)06341-2","volume":"355","author":"JP Julien","year":"2000","unstructured":"Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355(9203):528\u201333.","journal-title":"Lancet"},{"issue":"9378","key":"9003_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","volume":"362","author":"J Houghton","year":"2003","unstructured":"Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003;362(9378):95\u2013102.","journal-title":"Lancet"},{"issue":"2","key":"9003_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16(2):441\u201352.","journal-title":"J Clin Oncol"},{"issue":"6","key":"9003_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"32","key":"9003_CR20","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","volume":"27","author":"LL Hughes","year":"2009","unstructured":"Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319\u201324.","journal-title":"J Clin Oncol"},{"issue":"33","key":"9003_CR21","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","volume":"33","author":"LJ Solin","year":"2015","unstructured":"Solin LJ, Gray R, Hughes LL, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015;33(33):3938\u201344.","journal-title":"J Clin Oncol"},{"issue":"5","key":"9003_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ijrobp.2006.03.009","volume":"65","author":"GL Smith","year":"2006","unstructured":"Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2006;65(5):1397\u2013403.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"9003_CR23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","volume":"34","author":"Y Sagara","year":"2016","unstructured":"Sagara Y, Freedman RA, Vaz-Luis I, et al. Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study. J Clin Oncol. 2016;34(11):1190\u20136.","journal-title":"J Clin Oncol"},{"key":"9003_CR24","unstructured":"National Cancer Institute: Surveillance, Epidemiology, and End Results Program. http:\/\/seer.cancer.gov\/."},{"issue":"10","key":"9003_CR25","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1093\/ndt\/gft221","volume":"28","author":"MC de Goeij","year":"2013","unstructured":"de Goeij MC, van Diepen M, Jager KJ, Tripepi G, Zoccali C, Dekker FW. Multiple imputation: dealing with missing data. Nephrol Dial Transplant. 2013;28(10):2415\u201320.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"9003_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1541-0420.2011.01666.x","volume":"68","author":"SR Seaman","year":"2012","unstructured":"Seaman SR, White IR, Copas AJ, Li L. Combining multiple imputation and inverse-probability weighting. Biometrics. 2012;68(1):129\u201337.","journal-title":"Biometrics"},{"issue":"8","key":"9003_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","volume":"16","author":"DY Lin","year":"1997","unstructured":"Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16(8):901\u201310.","journal-title":"Stat Med"},{"issue":"3","key":"9003_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/atm.2016.08.62","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang Z. Survival analysis in the presence of competing risks. Ann Transl Med. 2017;5(3):47.","journal-title":"Ann Transl Med"},{"issue":"24","key":"9003_CR29","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1002\/sim.1357","volume":"21","author":"S Galimberti","year":"2002","unstructured":"Galimberti S, Sasieni P, Valsecchi MG. A weighted Kaplan\u2013Meier estimator for matched data with application to the comparison of chemotherapy and bone-marrow transplant in leukaemia. Stat Med. 2002;21(24):3847\u201364.","journal-title":"Stat Med"},{"issue":"7","key":"9003_CR30","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242\u201358.","journal-title":"Stat Med"},{"key":"9003_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"7","key":"9003_CR32","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00432-019-02930-2","volume":"145","author":"CW Goh","year":"2019","unstructured":"Goh CW, Wu J, Ding S, et al. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC\/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. J Cancer Res Clin Oncol. 2019;145(7):1877\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"9003_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1245\/ASO.2003.11.011","volume":"10","author":"LE Hoorntje","year":"2003","unstructured":"Hoorntje LE, Schipper ME, Peeters PH, Bellot F, Storm RK, Borel Rinkes IH. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in situ: causes of ductal carcinoma-in situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol. 2003;10(7):748\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"9003_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229\u201337.","journal-title":"N Engl J Med"},{"issue":"9205","key":"9003_CR35","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0140-6736(99)03703-4","volume":"355","author":"F Warnberg","year":"2000","unstructured":"Warnberg F, Yuen J, Holmberg L. Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet. 2000;355(9205):724\u20135.","journal-title":"Lancet"},{"issue":"3","key":"9003_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10549-009-0675-8","volume":"123","author":"L Burkhardt","year":"2010","unstructured":"Burkhardt L, Grob TJ, Hermann I, et al. Gene amplification in ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2010;123(3):757\u201365.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9003_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","volume":"104","author":"SE Clark","year":"2011","unstructured":"Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer. 2011;104(1):120\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"9003_CR38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s12032-014-0838-2","volume":"31","author":"D Cante","year":"2014","unstructured":"Cante D, Franco P, Sciacero P, et al. Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series. Med Oncol. 2014;31(2):838.","journal-title":"Med Oncol"},{"issue":"8","key":"9003_CR39","first-page":"3503","volume":"33","author":"M Guenzi","year":"2013","unstructured":"Guenzi M, Giannelli F, Bosetti D, et al. Two different hypofractionated breast radiotherapy schedules for 113 patients with ductal carcinoma in situ: preliminary results. Anticancer Res. 2013;33(8):3503\u20137.","journal-title":"Anticancer Res"},{"issue":"11","key":"9003_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","journal-title":"N Engl J Med"},{"issue":"3","key":"9003_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1634\/theoncologist.2011-0282","volume":"17","author":"GR Sheth","year":"2012","unstructured":"Sheth GR, Cranmer LD, Smith BD, Grasso-Lebeau L, Lang JE. Radiation-induced sarcoma of the breast: a systematic review. Oncologist. 2012;17(3):405\u201318.","journal-title":"Oncologist"},{"issue":"5","key":"9003_CR42","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.breast.2010.04.006","volume":"19","author":"E Erel","year":"2010","unstructured":"Erel E, Vlachou E, Athanasiadou M, Hassan S, Chandrasekar CR, Peart F. Management of radiation-induced sarcomas in a tertiary referral centre: a review of 25 cases. Breast. 2010;19(5):424\u20137.","journal-title":"Breast"},{"key":"9003_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7800-3-18","volume":"3","author":"CA Quadros","year":"2006","unstructured":"Quadros CA, Vasconcelos A, Andrade R, et al. Good outcome after neoadjuvant chemotherapy and extended surgical resection for a large radiation-induced high-grade breast sarcoma. Int Semin Surg Oncol. 2006;3:18.","journal-title":"Int Semin Surg Oncol"},{"issue":"2","key":"9003_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4143\/crt.2015.171","volume":"48","author":"KS Kim","year":"2016","unstructured":"Kim KS, Chang JH, Choi N, et al. Radiation-induced sarcoma: a 15-year experience in a single large tertiary referral center. Cancer Res Treat. 2016;48(2):650\u20137.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"9003_CR45","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1245\/s10434-019-08085-1","volume":"27","author":"SH Salminen","year":"2020","unstructured":"Salminen SH, Wiklund T, Sampo MM, et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol. 2020;27(4):1002\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"9003_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","volume":"150","author":"Y Sagara","year":"2015","unstructured":"Sagara Y, Mallory MA, Wong S, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg. 2015;150(8):739\u201345.","journal-title":"JAMA Surg"},{"issue":"12","key":"9003_CR47","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S1470-2045(12)70503-X","volume":"13","author":"L Fallowfield","year":"2012","unstructured":"Fallowfield L, Francis A, Catt S, Mackenzie M, Jenkins V. Time for a low-risk DCIS trial: harnessing public and patient involvement. Lancet Oncol. 2012;13(12):1183\u20135.","journal-title":"Lancet Oncol"},{"issue":"7","key":"9003_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","volume":"33","author":"B McCormick","year":"2015","unstructured":"McCormick B, Winter K, Hudis C, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33(7):709\u201315.","journal-title":"J Clin Oncol"},{"issue":"4","key":"9003_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","volume":"186","author":"MJ Silverstein","year":"2003","unstructured":"Silverstein MJ. The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186(4):337\u201343.","journal-title":"Am J Surg"},{"issue":"23","key":"9003_CR50","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","volume":"28","author":"U Rudloff","year":"2010","unstructured":"Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762\u20139.","journal-title":"J Clin Oncol"},{"issue":"10","key":"9003_CR51","first-page":"890","volume":"25","author":"E Revesz","year":"2011","unstructured":"Revesz E, Khan SA. What are safe margins of resection for invasive and in situ breast cancer? Oncology (Williston Park). 2011;25(10):890\u20135.","journal-title":"Oncology (Williston Park)"},{"issue":"7","key":"9003_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jnci\/djs142","volume":"104","author":"SY Wang","year":"2012","unstructured":"Wang SY, Chu H, Shamliyan T, et al. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst. 2012;104(7):507\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"9003_CR53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105(10):701\u201310.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9003_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13058-019-1165-5","volume":"21","author":"S Klimov","year":"2019","unstructured":"Klimov S, Miligy IM, Gertych A, et al. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk. Breast Cancer Res. 2019;21(1):83.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"9003_CR55","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0","volume":"76","author":"DL Page","year":"1995","unstructured":"Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15\u201325\u00a0years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197\u2013200.","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09003-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09003-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09003-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:14:59Z","timestamp":1628813699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09003-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["9003"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09003-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"6 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have disclosed no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}